SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: khrnyc who wrote (2120)1/29/1998 4:23:00 AM
From: Bill Wexler  Read Replies (2) of 7041
 
Keith. I re-read your post carefully, and something else struck me as quite odd.

It was the last two paragraphs:

<<These fluctuations in stock price are irrelevent. At the end of the day what will matter is whether or not Zona has a product, patent protection, and the ability to market their product in light of the competition.

In my opinion they have all three; and their tiny current market cap is going to allow those well informed investors to profit out of the present confusion.>>

The only thing that's missing is a little touch-up work by a proofreader. Keith, this sounds like the type of shillspeak that pops up on the fax machines of dozens of fund managers and other potential suckers every morning.

Keith, are you absolutely certain that if I started to do a little digging, I would find no connection between Keith Rubin (or whoever you really are) and Zonagen?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext